Children aged 5 to 11 now have access to bivalent booster for COVID-19

CBC News | Dec. 9, 2022, 9:24 a.m. | Original

The Pfizer-BioNTech "bivalent" shot protects against the most prevalent subvariants of Omicron, BA.4 and BA.5, and is the first approved for use in children between the ages of five and 11.

Keystone pipeline ordered shut down after leak of 14,000 barrels of oil Former police officer who kneeled on George Floyd's back sentenced to more than 3 years in prison